Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
women
Biotech
Investors fork out $76M for piece of Pheast's cancer therapies
Pheast closes out a $76 million Series A funding round, fueled by its development of checkpoint therapies to fight cancer with “don’t eat me” therapy
Gabrielle Masson
Apr 26, 2022 11:00am
Twist is doing better than most on ESG, but opportunities remain
Jan 31, 2022 4:45pm
AC Immune CEO says 2021 was a breakthrough year for Alzheimer's
Dec 21, 2021 9:15am
Stroke trials don't match prevalence of disease in women: study
Oct 26, 2021 11:07am
Organon launches ready to shop for women's health companies
Jun 4, 2021 9:20am
Women's health-focused Celmatix snags Merck KGaA vet as CSO
May 26, 2021 10:28am
